Company Overview & Brief History

The struggle that women with AUB condition have in maintaining a typical day to day quality of life is real. AUB not only affects the physical health of the woman like becoming anemic, but it also has a traumatic impact on their quality of life, relationships, work or education.

Although there are currently a number of different approaches to addressing AUB, there are still a large segment of the women who could benefit from a technology like ours which we believe will not only provide new options for treatment of AUB to the currently indicated population, but will open up alternative treatment for women that can’t be treated with similar technologies today.

Our team has worked in the medical technology field for multiple decades providing high quality, new technologies  that improve patients lives all over the world.

We wanted to bring that expertise to Aqua Therapeutics^TM with the intention of improving the outcomes of women who suffer from AUB. Our complete focus is to develop a purely women-centric treatment which is safe and effective while being easy for the physician to use in their office.

Currently we have successfully completed all the design and pre-clinical work necessary to begin our formal clinical studies.

We have identified well-respected medical institutions who have world renowned expertise in treating AUB with a variety of treatments.

We have received approval from European Health Authorities to begin our clinical studies.

Our goal is to begin our studies in the 4th quarter of 2024.